Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Family with sequence similarity 47 member E (FAM47E) is a protein localized to the chromatin, cytoplasm, and nucleus, where it acts as an activator of the protein arginine methyltransferase PRMT5, promoting PRMT5-mediated histone arginine methylation and supporting chromatin-associated epigenetic gene regulation[1][3]. Overexpression of FAM47E leads to stabilization and chromatin localization of PRMT5, influencing the expression of various PRMT5 target genes and promoting cell proliferation and colony formation, suggesting an oncogenic potential through the PRMT5 axis[1]. It is not a classical therapeutic target such as a receptor, enzyme, transporter, or ion channel, but is classified under “Other” as a chromatin and transcription regulatory protein[1][3]. Currently, no drugs or targeted inhibitors of FAM47E are described in the literature, and it is not established as a clinical biomarker or safety concern.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Family with sequence similarity 47 member E (FAM47E).